The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1079324413 10793244 13 F 2005 20160912 20150213 20160914 EXP US-PFIZER INC-2015057347 PFIZER 68.00 YR F Y 98.00000 KG 20160914 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1079324413 10793244 1 PS LYRICA PREGABALIN 1 Oral UNK 21446 CAPSULE, HARD
1079324413 10793244 2 SS LYRICA PREGABALIN 1 Oral 300 MG, 2X/DAY L05300 21446 300 MG CAPSULE, HARD BID
1079324413 10793244 3 SS LYRICA PREGABALIN 1 21446 CAPSULE, HARD
1079324413 10793244 4 SS GABAPENTIN. GABAPENTIN 1 Oral 300 MG, 3X/DAY BEDTIME 20235 300 MG CAPSULE, HARD TID
1079324413 10793244 5 SS ATENOLOL. ATENOLOL 1 Oral 25 MG, 1X/DAY 73676 25 MG TABLET QD
1079324413 10793244 6 SS ATENOLOL. ATENOLOL 1 Oral 50 MG, UNK 73676 50 MG TABLET
1079324413 10793244 7 SS ATENOLOL. ATENOLOL 1 Oral 25 MG, 1X/DAY (EVERY MORNING) 73676 25 MG TABLET QD
1079324413 10793244 8 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral 40 MG, 1X/DAY (30 MIN. BEFORE BREAKFAST) 0 40 MG MODIFIED-RELEASE CAPSULE, HARD QD
1079324413 10793244 9 SS FLUOXETINE HCL FLUOXETINE HYDROCHLORIDE 1 40 MG, 1X/DAY 0 40 MG CAPSULE QD
1079324413 10793244 10 SS FLUOXETINE HCL FLUOXETINE HYDROCHLORIDE 1 Oral 120 MG, DAILY 0 120 MG CAPSULE
1079324413 10793244 11 SS FLUOXETINE HCL FLUOXETINE HYDROCHLORIDE 1 Oral 40 MG, DAILY 0 40 MG CAPSULE
1079324413 10793244 12 C ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM 1 Oral 20 MG, 1X/DAY 0 20 MG TABLET QD
1079324413 10793244 13 C FLUTICASON FLUTICASONEFLUTICASONE PROPIONATE 1 Nasal 4 DF, 1X/DAY (50 MCG/ACT, 2 SPRAYS EACH NOSTRIL A TIME A DAY) 0 4 DF NASAL SPRAY, SUSPENSION QD
1079324413 10793244 14 C FLUTICASON FLUTICASONEFLUTICASONE PROPIONATE 1 Nasal 50 UG, 2 SPRAY EACH NOSTRIL DAILY 0 200 UG NASAL SPRAY, SUSPENSION
1079324413 10793244 15 C HYDROCODONE W/ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral 7.5-325 MG, 1 DF 0 1 DF TABLET
1079324413 10793244 16 C MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 Oral 10 MG, DAILY 0 10 MG TABLET
1079324413 10793244 17 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 2 DF, AS NEEDED (EVERY SIX HOURS) 0 2 DF INHALATION VAPOUR, SOLUTION
1079324413 10793244 18 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 0.083% OF 2.5 MG/3 ML AT ONE NEBULIZED SOLUTION FOUR TIMES DAILY 0 1 DF INHALATION VAPOUR, SOLUTION QID
1079324413 10793244 19 C CELEBREX CELECOXIB 1 Oral 200 MG, DAILY 0 200 MG CAPSULE
1079324413 10793244 20 C CELEBREX CELECOXIB 1 Oral 100 MG, DAILY (WITH FOOD) 0 100 MG CAPSULE
1079324413 10793244 21 C CELEX 2 UNK 0
1079324413 10793244 22 C MULTIVITAMINS VITAMINS 1 UNK 0
1079324413 10793244 23 C LOSARTAN POTASSIUM/HCTZ 2 1 TABLET (50-12.5 MG), DAILY 0 1 DF TABLET
1079324413 10793244 24 C LIPITOR ATORVASTATIN CALCIUM 1 20 MG, DAILY 0 20 MG TABLET
1079324413 10793244 25 C LORAZEPAM. LORAZEPAM 1 0.5 MG, EVERY 12 HOURS AS NEEDED 0 .5 MG TABLET
1079324413 10793244 26 C LORAZEPAM. LORAZEPAM 1 0 TABLET
1079324413 10793244 27 C REQUIP ROPINIROLE HYDROCHLORIDE 1 Oral 2 MG, 1X/DAY (AT BEDTIME) 0 2 MG TABLET QD
1079324413 10793244 28 C ATROVENT IPRATROPIUM BROMIDE 1 Nasal 0.03 % AS NEEDED AT 2 NASAL TWICE TO THREE TIMES 0 2 DF
1079324413 10793244 29 C ASTEPRO AZELASTINE HYDROCHLORIDE 1 Nasal 0.15 % AS NEEDED AT 2 NASAL DAILY AT BEDTIME 0 2 DF

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1079324413 10793244 1 Neuralgia
1079324413 10793244 2 Limb discomfort
1079324413 10793244 3 Back pain
1079324413 10793244 17 Asthma
1079324413 10793244 19 Osteoarthritis
1079324413 10793244 20 Arthritis
1079324413 10793244 23 Essential hypertension
1079324413 10793244 25 Anxiety
1079324413 10793244 26 Depression

Outcome of event

Event ID CASEID OUTC COD
1079324413 10793244 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1079324413 10793244 Abdominal pain
1079324413 10793244 Abdominal pain upper
1079324413 10793244 Hypoacusis
1079324413 10793244 Limb discomfort
1079324413 10793244 Neuralgia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1079324413 10793244 1 2005 0
1079324413 10793244 2 2010 0
1079324413 10793244 4 2010 0
1079324413 10793244 7 20151001 0
1079324413 10793244 8 2013 0
1079324413 10793244 9 2010 0
1079324413 10793244 11 20151221 0
1079324413 10793244 12 2005 0
1079324413 10793244 14 20150923 0
1079324413 10793244 18 20160118 0
1079324413 10793244 19 20120912 0
1079324413 10793244 23 20140811 0
1079324413 10793244 24 20160209 0
1079324413 10793244 25 20160118 0